4
Changes in Ownership
HCW Biologics Inc. Filed Acc 0001209191-23-049314
Chief Financial Officer bought 10,000 shares at an average $2.07 ($20,715)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Byam Rebecca Chief Financial Officer | 2023-09-11 | Purchase | +5,000 | $2.05 | $10,273 | 563,946 | D |
| Byam Rebecca Chief Financial Officer | 2023-09-12 | Purchase | +5,000 | $2.09 | $10,442 | 568,946 | D |
| Open-market purchases · 10,000 sh · avg $2.07 · $20,715 | |||||||
Loading xslF345X05/doc4.xml…